Drugs Made In America Acquisition (DMAAR) Long-Term Investments (2025)
Drugs Made In America Acquisition (DMAAR) posted Long-Term Investments of $239.9 million for Q4 2025, up 0.97% on a QoQ basis from $237.6 million in Q3 2025.
Drugs Made In America Acquisition (DMAAR) Long-Term Investments (2025) Analysis & Trends
Drugs Made In America Acquisition's Long-Term Investments history runs 1 years deep, the most recent figure standing at $239.9 million for Q4 2025.
- Quarterly Long-Term Investments changed N/A year-over-year to $239.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $239.9 million (changed N/A YoY) and the FY2025 annual result came in at $239.9 million, changed N/A from the prior year.
- Long-Term Investments was $239.9 million for Q4 2025 at Drugs Made In America Acquisition, up from $237.6 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $239.9 million in Q4 2025 and bottomed at $232.7 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | SIM Acquisition Corp. I | 314.52 Mn | 314.52 Mn | - | 247.27 Mn |
| 2 | Thayer Ventures Acquisition | 208.29 Mn | 208.29 Mn | - | 206.36 Mn |
| 3 | Newbury Street II Acquisition | 185.26 Mn | 185.26 Mn | - | 183.45 Mn |
| 4 | Dynamix | 178.78 Mn | 178.78 Mn | - | 173.39 Mn |
| 5 | Hallmark Venture | 103.01 Mn | 102.76 Mn | - | - |
| 6 | Voyager Acquisition | 99.58 Mn | 99.45 Mn | - | 269.86 Mn |
| 7 | Gores Holdings X | 95.80 Mn | 95.37 Mn | - | 374.14 Mn |
| 8 | Archimedes Tech SPAC Partners | 89.88 Mn | 89.88 Mn | - | 239.86 Mn |
| 9 | Cohen Circle Acquisition | 80.05 Mn | 80.05 Mn | - | 259.92 Mn |
| 10 | Drugs Made In America Acquisition | 1.46 Mn | 1.46 Mn | - | 239.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 239.91 Mn |
| Sep 30, 2025 | 237.60 Mn |
| Jun 30, 2025 | 235.16 Mn |
| Mar 31, 2025 | 232.74 Mn |